Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
364.58
275.67
228.46
194.62
153.28
123.51
113.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
364.58
275.67
228.46
194.62
153.28
123.51
113.24
Raw Material Cost
92.76
78.53
63.26
43.31
33.47
24.62
20.26
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
97.56
75.96
0.00
0.00
0.00
37.13
34.76
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.32
1.16
2.41
1.93
0.61
0.13
0.15
Selling and Distribution Expenses
121.94
95.20
96.96
96.15
68.39
56.89
63.42
Other Expenses
-6.31
-5.21
2.19
2.60
2.35
-2.24
-1.87
Total Expenditure (Excl Depreciation)
249.50
198.79
184.53
167.42
125.94
96.36
99.85
Operating Profit (PBDIT) excl Other Income
115.1
76.9
43.9
27.200000000000003
27.3
27.200000000000003
13.4
Other Income
18.06
20.05
8.29
16.43
24.31
17.11
18.44
Operating Profit (PBDIT)
156.55
122.57
76.86
58.71
60.88
49.16
36.49
Interest
0.32
1.16
2.41
1.93
0.61
0.13
0.15
Exceptional Items
-1.99
-0.33
0.13
-0.31
0.98
0.40
0.73
Gross Profit (PBDT)
271.83
197.14
165.21
151.32
119.81
98.89
92.98
Depreciation
28.07
27.91
26.55
16.51
9.65
6.43
6.01
Profit Before Tax
126.17
93.16
48.02
39.96
51.60
43.00
31.06
Tax
13.04
14.30
7.14
4.23
6.92
6.15
3.48
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
113.13
78.85
40.88
35.89
44.71
36.97
27.68
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
113.13
78.85
40.88
35.89
44.71
36.97
27.68
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
-0.16
-0.03
-0.11
-0.10
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
113.13
78.85
40.88
35.73
44.68
36.86
27.58
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
798.06
699.66
635.86
602.58
572.26
336.00
299.03
Earnings per share (EPS)
1.69
1.19
0.62
0.54
0.68
0.56
0.42
Diluted Earnings per share
1.69
1.19
0.62
0.54
0.68
0.56
0.42
Operating Profit Margin (Excl OI)
30.29%
27.06%
18.39%
13.24%
17.57%
20.74%
10.63%
Gross Profit Margin
42.31%
43.92%
32.64%
29.02%
39.96%
40.02%
32.74%
PAT Margin
31.03%
28.6%
17.89%
18.44%
29.17%
29.93%
24.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 32.25% vs 20.66% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 43.35% vs 92.91% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 35.12% vs 49.42% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -75.00% vs -50.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Medprin Regenerative Medical Technologies Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
364.58
0
364.58
Other Operating Income
0.00
0.00
0.00
Total Operating income
364.58
0
364.58
Raw Material Cost
92.76
0
92.76
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
97.56
0
97.56
Power Cost
0
0
0.00
Manufacturing Expenses
0.32
0
0.32
Selling and Distribution Expenses
121.94
0
121.94
Other Expenses
-6.31
0.00
-6.31
Total Expenditure (Excl Depreciation)
249.50
0
249.50
Operating Profit (PBDIT) excl Other Income
115.08
0.00
115.08
Other Income
18.06
0
18.06
Operating Profit (PBDIT)
156.55
0
156.55
Interest
0.32
0
0.32
Exceptional Items
-1.99
0
-1.99
Gross Profit (PBDT)
271.83
0
271.83
Depreciation
28.07
0
28.07
Profit Before Tax
126.17
0
126.17
Tax
13.04
0
13.04
Provisions and contingencies
0
0
0.00
Profit After Tax
113.13
0
113.13
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
113.13
0
113.13
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
113.13
0
113.13
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
798.06
0
798.06
Earnings per share (EPS)
1.69
0
1.69
Diluted Earnings per share
1.69
0
1.69
Operating Profit Margin (Excl OI)
30.29%
0%
0.00
30.29%
Gross Profit Margin
42.31%
0%
0.00
42.31%
PAT Margin
31.03%
0%
0.00
31.03%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 36.46 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 32.25% vs 20.66% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 11.31 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 43.35% vs 92.91% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.85 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 35.12% vs 49.42% in Dec 2024
Annual - Interest
Interest 0.03 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -75.00% vs -50.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.29%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






